Tevogen Bio Holdings Inc. (TVGNW) — 8-K Filings

8-K Filings (21)

• Tevogen Bio Holdings Faces Delisting Notice — Sep 26, 2025 Risk: high
  Tevogen Bio Holdings Inc. filed an 8-K on September 23, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, forme
• Tevogen Bio Holdings Files 8-K: Other Event — Jul 10, 2025 Risk: medium
  Tevogen Bio Holdings Inc. filed an 8-K on July 10, 2025, reporting an "Other Event." The filing does not contain specific details about the event, dollar amount
• Tevogen Bio Holdings Files 8-K — Jul 3, 2025 Risk: low
  Tevogen Bio Holdings Inc. filed an 8-K on July 3, 2025, reporting an entry into a material definitive agreement and financial statements. The company, formerly
• Tevogen Bio Holdings Inc. Files 8-K — Jun 30, 2025 Risk: low
  Tevogen Bio Holdings Inc. filed an 8-K on June 30, 2025, reporting "Other Events." The filing indicates the company was formerly known as Semper Paratus Acquisi
• Tevogen Bio Holdings Files 8-K on Security Holder Vote Matters — Jun 23, 2025 Risk: low
  Tevogen Bio Holdings Inc. filed an 8-K on June 23, 2025, to report on the submission of matters to a vote of its security holders. The company, formerly known a
• Tevogen Bio Holdings Inc. Files Form 8-K — Jun 3, 2025 Risk: low
  Tevogen Bio Holdings Inc. entered into a material definitive agreement on May 30, 2025. The company, formerly Semper Paratus Acquisition Corp., is incorporated
• Tevogen Bio Holdings Files 8-K — Apr 17, 2025 Risk: low
  Tevogen Bio Holdings Inc. filed an 8-K on April 17, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contai
• Tevogen Bio Holdings Files 8-K — Jan 28, 2025 Risk: low
  Tevogen Bio Holdings Inc. filed an 8-K on January 28, 2025, reporting on various events. The filing includes information related to its common stock and warrant
• Tevogen Bio Holdings Inc. Files 8-K with Key Corporate Updates — Aug 23, 2024 Risk: medium
  Tevogen Bio Holdings Inc. announced on August 20, 2024, an entry into a material definitive agreement, potentially related to unregistered sales of equity secur
• Tevogen Bio Holdings Inc. Terminates Agreement, Faces Delisting Notice — Jun 21, 2024 Risk: high
  Tevogen Bio Holdings Inc. announced on June 14, 2024, the termination of a material definitive agreement and entered into a new one. The company also received a
• Tevogen Bio Holdings Inc. Reports Material Definitive Agreement — Jun 11, 2024 Risk: medium
  On June 6, 2024, Tevogen Bio Holdings Inc. entered into a material definitive agreement, creating a direct financial obligation. The company also reported on th
• Tevogen Bio Holdings Inc. Enters Material Definitive Agreement — May 16, 2024 Risk: medium
  Tevogen Bio Holdings Inc. announced on May 10, 2024, that it entered into a material definitive agreement. The company, formerly known as Semper Paratus Acquisi
• Tevogen Bio Holdings Inc. Changes Certifying Accountant — May 2, 2024 Risk: medium
  Tevogen Bio Holdings Inc. filed an 8-K on April 29, 2024, reporting a change in its certifying accountant. The company previously engaged WithumSmith+Brown, PC
• Tevogen Bio Holdings Files 8-K on Financials — Apr 26, 2024 Risk: medium
  Tevogen Bio Holdings Inc. filed an 8-K on April 26, 2024, reporting on its results of operations and financial condition, as well as financial statements and ex
• Tevogen Bio Holdings Files 8-K on Material Agreement — Apr 2, 2024 Risk: medium
  Tevogen Bio Holdings Inc. filed an 8-K on March 27, 2024, reporting on a material definitive agreement and amendments to its articles of incorporation. The comp
• Tevogen Bio Holdings Files 8-K for Bylaw Amendments — Mar 21, 2024 Risk: low
  Tevogen Bio Holdings Inc. filed an 8-K on March 21, 2024, reporting events as of March 15, 2024. The filing primarily concerns amendments to its articles of inc
• Tevogen Bio Amends Code of Ethics, Details Stock & Warrant Values — Feb 21, 2024 Risk: low
  Tevogen Bio Holdings Inc. (NASDAQ: TVGN) filed an 8-K on February 21, 2024, reporting amendments to its Code of Ethics, effective February 14, 2024. The filing
• Semper Paratus Reports Acquisition, Equity Sales, and Control Changes — Feb 14, 2024 Risk: medium
  Semper Paratus Acquisition Corp filed an 8-K on February 14, 2024, reporting significant corporate actions including the entry into a material definitive agreem
• Semper Paratus Files 8-K on Shareholder Vote Matters — Feb 1, 2024
  Semper Paratus Acquisition Corp. filed an 8-K on February 1, 2024, reporting an event on January 31, 2024, related to the submission of matters to a vote of sec
• Semper Paratus Files 8-K for Rule 425 Compliance — Jan 24, 2024
  Semper Paratus Acquisition Corp. filed an 8-K on January 24, 2024, indicating it is satisfying filing obligations under Rule 425 of the Securities Act. This fil
• Semper Paratus Files Rule 425 Communication — Jan 5, 2024
  Semper Paratus Acquisition Corp. filed an 8-K on January 4, 2024, indicating it is making written communications under Rule 425 of the Securities Act. This fili

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX